MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202611023978 A) filed by Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, on Feb. 27, for 'a bioresorbable implant system comprising plga/pla polymer matrix with addressable electro-responsive reservoirs and native bioelectric signal-triggered controlled drug release.'
Inventor(s) include Deepak Singh Aswal.
The application for the patent was published on May 1, under issue no. 18/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a fully bioresorbable implantable medicine configured for condition-responsive controlled drug delivery. The implant comprises a biodegradable structural matrix formed from poly(lactic-co-glycolic acid) (PLGA), blended with polylactic acid (PLA) and/or polycaprolactone (PCL), defining a plurality of spatially isolated drug reservoirs. Each reservoir is operatively associated with an electro-gated membrane configured to modulate permeability upon controlled electrical stimulation. Bioresorbable sensing electrodes detect native bioelectric activity at a target tissue site, and a control circuitry module selectively activates a corresponding reservoir when predefined bioelectric signal characteristics are satisfied. The system delivers localized micro-dosing under programmed safety lockout mechanisms including refractory intervals and cumulative dose limits. Bioresorbable stimulation electrodes and conductive pathways enable transient operation without permanent implantation."
Disclaimer: Curated by HT Syndication.
